🔗 Share this article

Treasury head Reeves has stated she is preparing "targeted action to deal with household expense challenges" in next month's financial statement.

In comments to the BBC, she stated that lowering inflation is a collective responsibility of both the government and the Bank of England.

The UK's price growth is forecast to be the most elevated among the Group of Seven industrialized countries this year and next.

Possible Utility Cost Interventions

Reports indicate the government could take action to lower energy bills, for example by reducing the present 5% level of VAT charged on energy supplies.

Another option is to lower some of the regulatory levies presently included in bills.

Budgetary Constraints and Analyst Predictions

The administration will obtain the next draft from the independent fiscal watchdog, the OBR, on Monday, which will clarify how much space there is for these actions.

The view from the majority of economists is that the Chancellor will have to announce tax rises or budget cuts in order to fulfill her voluntary borrowing rules.

Previously on the same day, estimates suggested there was a £22 billion gap for the chancellor to address, which is at the lower end of projections.

"There's a collective task between the central bank and the government to bear down further on some of the sources of inflation," the Chancellor informed the BBC in Washington, at the conferences of the IMF and global financial institution.

Revenue Pledges and International Concerns

While much of the attention has been on probable tax increases, the chancellor said the most recent data from the OBR had not altered her vow to campaign commitments not to increase rates on income tax, sales tax or social security contributions.

She blamed an "unpredictable world" with growing geopolitical and commercial issues for the fiscal tax moves, likely to be directed on those "wealthiest."

International Trade Tensions

Addressing apprehensions about the UK's trade ties with the Asian nation she said: "The UK's national security invariably are paramount."

Last week's statement by Chinese authorities to strengthen export controls on rare earths and other resources that are crucial for advanced tech manufacturing led American leader Donald Trump to threaten an further 100% tariff on imports from China, increasing the risk of an all-out trade war between the two largest economies.

The US Treasury Secretary labeled the Chinese decision "commercial pressure" and "a international production control attempt."

Questioned on considering the US offer to participate in its dispute with China, the Chancellor said she was "extremely troubled" by Chinese measures and urged the Beijing authorities "to avoid restrictions and limit trade."

She said the action was "bad for the global economy and generates additional challenges."

"I believe there are sectors where we must confront Chinese policies, but there are also valuable opportunities to sell into Chinese markets, including financial services and other areas of the economy. We've got to get that balance appropriate."

The Treasury chief also affirmed she was collaborating with G7 counterparts "on our own critical minerals plan, so that we are more independent."

NHS Medicine Costs and Investment

The Chancellor also acknowledged that the cost the NHS pays for drugs could rise as a result of ongoing discussions with the US government and its pharmaceutical firms, in return for lower tariffs and capital.

Some of the world's largest pharmaceutical manufacturers have said recently that they are either delaying or abandoning operations in the UK, with some attributing the low prices they are receiving.

Last month, the government science advisor said the price the NHS spends on medicines would must rise to stop companies and drug research funding departing from the United Kingdom.

The Chancellor stated to media: "We have seen due to the pricing regime, that medical research, new drugs have not been available in the UK in the manner that they are in other European countries."

"We want to guarantee that people getting care from the NHS are can access the best critical drugs in the globe. And so we are reviewing this situation, and... seeking to secure increased capital into Britain."